The Australian government is investing $9.2 million in 12 new health and medical research projects, transforming their ideas into innovative, life-saving medicines, devices and treatments for the patients of the future.

Through the landmark Medical Research Future Fund, the government is providing $9.2 million across two programs – $5.2 million to develop new approaches that tackle diabetes and cardiovascular disease, and $4 million to develop new medical technologies to treat a range of conditions.

The funding is provided through two programs – the Targeted Translation Research Accelerator (TTRA) and BioMedTech Horizons (BMTH) – which aim to support the development of novel preventive, diagnostic and therapeutic approaches and products for diabetes and cardiovascular disease, and translation and commercialisation of world-leading health and medical research projects.

Targeted Translation Research Accelerator ($5.2 million to seven projects)

BioMedTech Horizons (total funding of $4 million to five projects)